These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2536295

  • 1. Studies of topoisomerase-specific antitumor drugs in human lymphocytes using rabbit antisera against recombinant human topoisomerase II polypeptide.
    Hwang JL, Shyy SH, Chen AY, Juan CC, Whang-Peng J.
    Cancer Res; 1989 Feb 15; 49(4):958-62. PubMed ID: 2536295
    [Abstract] [Full Text] [Related]

  • 2. Induction of topoisomerase II gene expression in human lymphocytes upon phytohemagglutinin stimulation.
    Hwong CL, Wang CH, Chen YJ, Whang-Peng J, Hwang JL.
    Cancer Res; 1990 Sep 01; 50(17 Suppl):5649S-5652S. PubMed ID: 2167162
    [Abstract] [Full Text] [Related]

  • 3. Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines.
    Matsuo K, Kohno K, Takano H, Sato S, Kiue A, Kuwano M.
    Cancer Res; 1990 Sep 15; 50(18):5819-24. PubMed ID: 2168282
    [Abstract] [Full Text] [Related]

  • 4. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
    Long BH, Musial ST, Brattain MG.
    Cancer Res; 1986 Aug 15; 46(8):3809-16. PubMed ID: 3015377
    [Abstract] [Full Text] [Related]

  • 5. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K, Petersen BO, Falck J, Helin K, Jensen PB, Sehested M.
    Clin Cancer Res; 2000 Apr 15; 6(4):1488-97. PubMed ID: 10778981
    [Abstract] [Full Text] [Related]

  • 6. Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells.
    Yang L, Rowe TC, Liu LF.
    Cancer Res; 1985 Nov 15; 45(11 Pt 2):5872-6. PubMed ID: 2996763
    [Abstract] [Full Text] [Related]

  • 7. Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin.
    Bjornsti MA, Benedetti P, Viglianti GA, Wang JC.
    Cancer Res; 1989 Nov 15; 49(22):6318-23. PubMed ID: 2553253
    [Abstract] [Full Text] [Related]

  • 8. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F, Bae I, Fornace AJ, Pommier Y.
    Oncol Res; 1996 Nov 15; 8(7-8):317-23. PubMed ID: 8938795
    [Abstract] [Full Text] [Related]

  • 9. Involvement of intracellular ATP in cytotoxicity of topoisomerase II-targetting antitumor drugs.
    Kupfer G, Bodley AL, Liu LF.
    NCI Monogr; 1987 Nov 15; (4):37-40. PubMed ID: 2819729
    [Abstract] [Full Text] [Related]

  • 10. Arrest of replication fork progression at sites of topoisomerase II-mediated DNA cleavage in human leukemia CEM cells incubated with VM-26.
    Catapano CV, Carbone GM, Pisani F, Qiu J, Fernandes DJ.
    Biochemistry; 1997 May 13; 36(19):5739-48. PubMed ID: 9153414
    [Abstract] [Full Text] [Related]

  • 11. Position-specific effects of base mismatch on mammalian topoisomerase II DNA cleaving activity.
    Bigioni M, Zunino F, Tinelli S, Austin CA, Willmore E, Capranico G.
    Biochemistry; 1996 Jan 09; 35(1):153-9. PubMed ID: 8555169
    [Abstract] [Full Text] [Related]

  • 12. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells.
    Holm C, Covey JM, Kerrigan D, Pommier Y.
    Cancer Res; 1989 Nov 15; 49(22):6365-8. PubMed ID: 2553254
    [Abstract] [Full Text] [Related]

  • 13. Altered formation of DNA in human cells treated with inhibitors of DNA topoisomerase II (etoposide and teniposide).
    Lönn U, Lönn S, Nylen U, Winblad G.
    Cancer Res; 1989 Nov 15; 49(22):6202-7. PubMed ID: 2553248
    [Abstract] [Full Text] [Related]

  • 14. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
    Schneider E, Horton JK, Yang CH, Nakagawa M, Cowan KH.
    Cancer Res; 1994 Jan 01; 54(1):152-8. PubMed ID: 7903202
    [Abstract] [Full Text] [Related]

  • 15. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
    Kubo T, Kohno K, Ohga T, Taniguchi K, Kawanami K, Wada M, Kuwano M.
    Cancer Res; 1995 Sep 01; 55(17):3860-4. PubMed ID: 7641205
    [Abstract] [Full Text] [Related]

  • 16. Analysis of expression and function of topoisomerase I and II during meiosis in male mice.
    Cobb J, Reddy RK, Park C, Handel MA.
    Mol Reprod Dev; 1997 Apr 01; 46(4):489-98. PubMed ID: 9094096
    [Abstract] [Full Text] [Related]

  • 17. Use of yeast in the study of anticancer drugs targeting DNA topoisomerases: expression of a functional recombinant human DNA topoisomerase II alpha in yeast.
    Wasserman RA, Austin CA, Fisher LM, Wang JC.
    Cancer Res; 1993 Aug 01; 53(15):3591-6. PubMed ID: 8393377
    [Abstract] [Full Text] [Related]

  • 18. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26.
    Kim R, Beck WT.
    Cancer Res; 1994 Sep 15; 54(18):4958-66. PubMed ID: 8069863
    [Abstract] [Full Text] [Related]

  • 19. Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I.
    Gupta RS, Gupta R, Eng B, Lock RB, Ross WE, Hertzberg RP, Caranfa MJ, Johnson RK.
    Cancer Res; 1988 Nov 15; 48(22):6404-10. PubMed ID: 2846151
    [Abstract] [Full Text] [Related]

  • 20. Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication.
    Schaack J, Schedl P, Shenk T.
    J Virol; 1990 Jan 15; 64(1):78-85. PubMed ID: 2152835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.